- Helps in controlling blood sugar levels in adults with type 2 diabetes.
- Reduces the risk of diabetes-related complications.
- Improves insulin sensitivity and decreases glucose production in the liver.
- Can be used as part of a comprehensive diabetes management plan that includes diet and exercise.
- May help in weight management compared to other diabetes medications.
- Convenient combination therapy reduces pill burden for patients.
- May lower the risk of cardiovascular events in diabetic patients.
Trajenta Duo 2.5/1000 mg Tablet - Strip of 10
Compositions : Linagliptin 2.5mg + Metformin Hydrochloride 1000mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Boehringer Ingelheim India Pvt. Ltd.
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Trajenta Duo 2.5/1000 mg Tablet is a prescription medication designed for the management of type 2 diabetes mellitus. This pharmaceutical product combines two active ingredients: Linagliptin and Metformin. Linagliptin is a DPP-4 inhibitor that helps to increase insulin levels and decrease glucagon levels in the bloodstream, thereby improving glycemic control. Metformin, on the other hand, is a biguanide that primarily works by decreasing hepatic glucose production and enhancing insulin sensitivity in peripheral tissues. The combination of these two agents in Trajenta Duo 2.5/1000 mg Tablet provides a synergistic effect, making it an effective option for patients who require additional glycemic control beyond what can be achieved with monotherapy. The tablet is typically prescribed when diet and exercise alone do not provide adequate blood sugar control. It is essential for patients to understand that Trajenta Duo 2.5/1000 mg Tablet is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis. The formulation is designed to be taken orally, and it is crucial for patients to adhere to their healthcare provider's instructions regarding dosage and administration to achieve optimal therapeutic outcomes.
Product Details
- Linagliptin inhibits the enzyme DPP-4, which leads to increased levels of incretin hormones.
- Increased incretin levels enhance insulin secretion from pancreatic beta cells in response to meals.
- Linagliptin also reduces glucagon secretion, which lowers hepatic glucose production.
- Metformin decreases glucose production in the liver and improves insulin sensitivity in muscle and fat tissues.
- The combination of these actions results in better overall glycemic control.
- Take Trajenta Duo 2.5/1000 mg Tablet orally with or without food, as directed by your healthcare provider.
- The usual starting dose is one tablet taken once daily.
- Dosage may be adjusted based on individual blood sugar levels and tolerance.
- Do not exceed the prescribed dosage without consulting your healthcare provider.
- It is important to take the medication at the same time each day to maintain consistent blood sugar control.
- If you miss a dose, take it as soon as you remember unless it is almost time for your next dose; do not double up on doses.
- Continue taking Trajenta Duo 2.5/1000 mg Tablet even if you feel well; do not stop without consulting your healthcare provider.
- Maintain a balanced diet rich in whole grains, fruits, vegetables, and lean proteins to support blood sugar control.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise per week.
- Monitor blood sugar levels regularly to understand how your body responds to the medication and lifestyle changes.
- Stay hydrated by drinking plenty of water throughout the day.
- Avoid excessive consumption of sugary foods and beverages that can spike blood sugar levels.
- Consider working with a registered dietitian for personalized meal planning and nutritional advice.
Safety Advice
Side Effects
- Common side effects may include nausea, vomiting, diarrhea, abdominal pain, and loss of appetite.
- Serious side effects can include lactic acidosis, pancreatitis, severe allergic reactions, and kidney problems.
- If you experience symptoms such as unusual tiredness, muscle pain, or difficulty breathing, seek medical attention immediately.
- Monitor for signs of low blood sugar (hypoglycemia), such as dizziness, sweating, confusion, or shakiness.
- Report any persistent or severe side effects to your healthcare provider promptly.
Precautions and Warnings
- Do not use Trajenta Duo if you have a history of hypersensitivity to Linagliptin or Metformin.
- Caution is advised in patients with renal impairment; kidney function should be monitored regularly.
- Avoid use in patients with severe liver disease or acute metabolic acidosis.
- Consult your healthcare provider before using if you are pregnant or breastfeeding.
- Alcohol consumption should be limited as it can increase the risk of lactic acidosis.
- Be cautious when driving or operating machinery until you know how Trajenta Duo affects you.
FAQs
Trajenta Duo 2.5/1000 mg Tablet is not suitable for individuals with type 1 diabetes or diabetic ketoacidosis. Always consult your healthcare provider before starting any new medication.
2. What should I do if I miss a dose of Trajenta Duo?
If you miss a dose, take it as soon as you remember unless it's close to your next scheduled dose. Do not take two doses at once.
3. Can I drink alcohol while taking Trajenta Duo?
Alcohol can affect blood sugar levels; consult your healthcare provider regarding alcohol consumption while on Trajenta Duo.
4. Are there any interactions with other medications?
Yes, Trajenta Duo may interact with certain medications. Always inform your healthcare provider about all medications you are taking.
5. How should I store Trajenta Duo 2.5/1000 mg Tablet?
Store Trajenta Duo at room temperature away from moisture and heat, and keep it out of reach of children.
6. Can pregnant or breastfeeding women use Trajenta Duo?
Consult your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding before using Trajenta Duo.
7. What are the common side effects of Trajenta Duo?
Common side effects may include gastrointestinal issues like nausea or diarrhea. Contact your healthcare provider if side effects persist.
Instructions
Directions for Use
Storage and Disposal
More Information
| SKU | 822011 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Boehringer Ingelheim India Pvt. Ltd. |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Trajenta Duo 2.5/1000 mg Tablet is a prescription medication designed for the management of type 2 diabetes mellitus. This pharmaceutical product combines two active ingredients: Linagliptin and Metformin. Linagliptin is a DPP-4 inhibitor that helps to increase insulin levels and decrease glucagon levels in the bloodstream, thereby improving glycemic control. Metformin, on the other hand, is a biguanide that primarily works by decreasing hepatic glucose production and enhancing insulin sensitivity in peripheral tissues. The combination of these two agents in Trajenta Duo 2.5/1000 mg Tablet provides a synergistic effect, making it an effective option for patients who require additional glycemic control beyond what can be achieved with monotherapy. The tablet is typically prescribed when diet and exercise alone do not provide adequate blood sugar control. It is essential for patients to understand that Trajenta Duo 2.5/1000 mg Tablet is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis. The formulation is designed to be taken orally, and it is crucial for patients to adhere to their healthcare provider's instructions regarding dosage and administration to achieve optimal therapeutic outcomes.
- Helps in controlling blood sugar levels in adults with type 2 diabetes.
- Reduces the risk of diabetes-related complications.
- Improves insulin sensitivity and decreases glucose production in the liver.
- Can be used as part of a comprehensive diabetes management plan that includes diet and exercise.
- May help in weight management compared to other diabetes medications.
- Convenient combination therapy reduces pill burden for patients.
- May lower the risk of cardiovascular events in diabetic patients.
- Linagliptin inhibits the enzyme DPP-4, which leads to increased levels of incretin hormones.
- Increased incretin levels enhance insulin secretion from pancreatic beta cells in response to meals.
- Linagliptin also reduces glucagon secretion, which lowers hepatic glucose production.
- Metformin decreases glucose production in the liver and improves insulin sensitivity in muscle and fat tissues.
- The combination of these actions results in better overall glycemic control.
- Take Trajenta Duo 2.5/1000 mg Tablet orally with or without food, as directed by your healthcare provider.
- The usual starting dose is one tablet taken once daily.
- Dosage may be adjusted based on individual blood sugar levels and tolerance.
- Do not exceed the prescribed dosage without consulting your healthcare provider.
- It is important to take the medication at the same time each day to maintain consistent blood sugar control.
- If you miss a dose, take it as soon as you remember unless it is almost time for your next dose; do not double up on doses.
- Continue taking Trajenta Duo 2.5/1000 mg Tablet even if you feel well; do not stop without consulting your healthcare provider.
- Maintain a balanced diet rich in whole grains, fruits, vegetables, and lean proteins to support blood sugar control.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise per week.
- Monitor blood sugar levels regularly to understand how your body responds to the medication and lifestyle changes.
- Stay hydrated by drinking plenty of water throughout the day.
- Avoid excessive consumption of sugary foods and beverages that can spike blood sugar levels.
- Consider working with a registered dietitian for personalized meal planning and nutritional advice.
Side Effects
- Common side effects may include nausea, vomiting, diarrhea, abdominal pain, and loss of appetite.
- Serious side effects can include lactic acidosis, pancreatitis, severe allergic reactions, and kidney problems.
- If you experience symptoms such as unusual tiredness, muscle pain, or difficulty breathing, seek medical attention immediately.
- Monitor for signs of low blood sugar (hypoglycemia), such as dizziness, sweating, confusion, or shakiness.
- Report any persistent or severe side effects to your healthcare provider promptly.
Precautions and Warnings
- Do not use Trajenta Duo if you have a history of hypersensitivity to Linagliptin or Metformin.
- Caution is advised in patients with renal impairment; kidney function should be monitored regularly.
- Avoid use in patients with severe liver disease or acute metabolic acidosis.
- Consult your healthcare provider before using if you are pregnant or breastfeeding.
- Alcohol consumption should be limited as it can increase the risk of lactic acidosis.
- Be cautious when driving or operating machinery until you know how Trajenta Duo affects you.
Trajenta Duo 2.5/1000 mg Tablet is not suitable for individuals with type 1 diabetes or diabetic ketoacidosis. Always consult your healthcare provider before starting any new medication.
2. What should I do if I miss a dose of Trajenta Duo?
If you miss a dose, take it as soon as you remember unless it's close to your next scheduled dose. Do not take two doses at once.
3. Can I drink alcohol while taking Trajenta Duo?
Alcohol can affect blood sugar levels; consult your healthcare provider regarding alcohol consumption while on Trajenta Duo.
4. Are there any interactions with other medications?
Yes, Trajenta Duo may interact with certain medications. Always inform your healthcare provider about all medications you are taking.
5. How should I store Trajenta Duo 2.5/1000 mg Tablet?
Store Trajenta Duo at room temperature away from moisture and heat, and keep it out of reach of children.
6. Can pregnant or breastfeeding women use Trajenta Duo?
Consult your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding before using Trajenta Duo.
7. What are the common side effects of Trajenta Duo?
Common side effects may include gastrointestinal issues like nausea or diarrhea. Contact your healthcare provider if side effects persist.
Directions for Use
Storage and Disposal
| SKU | 822011 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Boehringer Ingelheim India Pvt. Ltd. |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account